Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test Results of Fingerstick Blood Vary Significantly

By LabMedica International staff writers
Posted on 29 Nov 2015
Blood obtained via fingerstick is commonly used in point-of-care assays, but few studies have assessed variability in parameters obtained from successive drops of fingerstick blood, which may cause problems for clinical decision making and for assessing accuracy of point-of-care tests.

The most accurate way to carry out medial laboratory tests is to draw blood from a vein and send it to a laboratory but sometimes, such as in low-resource settings, results are needed more rapidly, or the health professional is not trained to draw vein-blood, or there is no laboratory. More...
In such settings, there is a higher reliance on fingerstick tests.

Bioengineers at Rice University (Houston, TX, USA) used a hematology analyzer to analyze the hemoglobin concentration, total white blood cell (WBC) count, three-part WBC differential, and platelet count in six successive 20 µL of blood collected from one fingerstick from each of 11 donors. The team used a hemoglobinometer to measure the hemoglobin concentration of 10 drops of fingerstick blood from each of seven donors to check whether the minimum droplet size made a difference and they checked all the results against blood taken from donors' veins. They also followed best practice to ensure accurate results. For example, they wiped away the first droplet to remove traces of disinfectant, and they did not squeeze or "milk" the finger.

The results showed that hemoglobin content, platelet count and white blood cell count varied significantly from drop to drop. The average percent coefficient of variation (CV) for successive drops of fingerstick blood was higher by up to 3.4 times for hemoglobin, 5.7 times for WBC count, three times for lymphocyte count, 7.7 times for granulocyte count, and four times for platelets than in venous controls measured using a hematology analyzer. The average percent CV for fingerstick blood was up to five times higher for hemoglobin than venous blood measured using a point-of-care hemoglobinometer. The investigators found that averaging the results of six to nine successive droplet tests produced results on a par with the venous blood tests.

Meaghan M. Bond, a doctoral student and first author of the study, said, “In some donors, the hemoglobin concentration changed by more than 2 g/dL in the span of two successive drops of blood. Our results show that people need to take care to administer fingerstick tests in a way that produces accurate results because accuracy in these tests is increasingly important for diagnosing conditions like anemia, infections and sickle-cell anemia, malaria, HIV and other diseases.” The study was published on November 18, 2015, in the American Journal of Clinical Pathology.

Related Links:

Rice University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.